<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr Virus (EBV) is prevalent in <z:hpo ids='HP_0000001'>all</z:hpo> human populations and high titers of antibody correlate with specific <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> such as Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Our study detected EBV DNA in 20 of 21 penile <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples using PCR reaction </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of EBV protein LMP-1 was identified in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells from two EBV PCR-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Our findings indicate that EBV can be implicated in rising and/or progression of <z:e sem="disease" ids="C0030849" disease_type="Neoplastic Process" abbrv="">penile tumors</z:e> independently of the histological type </plain></SENT>
</text></document>